RARA CRAFT DATABASE for FDA Medical Devices
510(k)K211218

FDA DEVICE FACTS

BD Alaris System with Guardrails Suite MX v12.1.2

Carefusion 303, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJuly 21, 2023PRODUCT CODEFRN

Indications for use

The BD Alaris System with Guardrails Suite MX is a modular infusion pump and monitoring system for the continuous or intermittent administration of fluids to adult, pediatric, and neonatal patients through clinically accepted routes of administration: intravenous (IV), intra-arterial (IA), subcutaneous, epidural, or irrigation of fluid spaces. See Pediatric*, Neonate**, and Adult Patient Population Tables for the module-specific variations. Administered fluids include pharmaceutical drugs, red blood cells, and other blood components (platelets and fresh frozen plasma) as required for patient therapy. The BD Alaris System with Guardrails Suite MX is an interoperable system capable of communicating and exchanging data with compatible information technology systems. The BD Alaris System with Guardrails Suite MX includes the PC Unit (PCU) and one or more of the following: Pump Module, Syringe Module, end-tidal CO 2 (EtCO2) Module, Auto-ID Module, Patient-Controlled Analgesia (PCA) Module, and associated software applications. EtCO2 Module is a capnograph that continuously monitors end-tidal carbon dioxide (EtCO2), fractional inspired carbon dioxide (FiCO2), and respiratory rate (RR). BD Alaris Pump Module and Syringe Module and the Alaris PCA Module are indicated for varying patient populations, routes of administration, and infusates. Table 1: Pediatric* and Neonate** Patient Populations Module Route of Administration Infusates BD Alaris™ Pump Module Intravenous Fluids, pharmaceutical drugs including high-alert medications, chemotherapy, and parenteral nutrition; red blood cells, platelets and fresh frozen plasma. Subcutaneous Fluids and pharmaceutical drugs approved for subcutaneous use. Epidural Pharmaceutical drugs approved for epidural use. Intra-arterial Pharmaceutical drugs approved for intra-arterial use. BD Alaris™ Syringe Module Intravenous Fluids, pharmaceutical drugs including high-alert medications, chemotherapy, and parenteral nutrition; red blood cells, platelets and fresh frozen plasma. Subcutaneous Pharmaceutical drugs approved for subcutaneous use. Epidural Pharmaceutical drugs approved for epidural use. Intra-arterial Pharmaceutical drugs approved for intra-arterial use. Alaris™ PCA Module Intravenous Pain management drugs approved for intravenous use. Epidural Pain management drugs approved for epidural use. * Pediatric population: One month to 21 years ** Neonate population: Newborns up to one month – includes preterm or term Table 2: Adult Patient Population Module Route of Administration Infusates BD Alaris™ Pump Module Intravenous Fluids, pharmaceutical drugs including high-alert medications, chemotherapy, and parenteral nutrition; red blood cells, platelets and fresh frozen plasma. Subcutaneous Fluids and pharmaceutical drugs approved for subcutaneous use. Epidural Pharmaceutical drugs approved for epidural use. Intra-arterial Pharmaceutical drugs approved for intra-arterial use. Irrigation of fluid spaces Fluids approved for irrigation. BD Alaris™ Syringe Module Intravenous Pharmaceutical drugs approved for intravenous use. Subcutaneous Pharmaceutical drugs approved for subcutaneous use. Epidural Pharmaceutical drugs approved for epidural use. Intra-arterial Pharmaceutical drugs approved for intra-arterial use. Alaris™ PCA Module Intravenous Pain management drugs approved for intravenous use. Subcutaneous Pain management drugs approved for subcutaneous use. Epidural Pain management drugs approved for epidural use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026